Search for: "State v. T. L. D." Results 4041 - 4060 of 4,188
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Apr 2015, 2:12 pm by Stephen Bilkis
There is no prima facie right to the custody of the children in either parent as "[t]he only absolute in the law governing custody of children is that there are no absolutes" (Friederwitzer v. [read post]
28 Jul 2008, 5:45 pm
., E. coli O121:H19) that can also cause hemorrhagic colitis and post-diarrheal hemolytic uremic syndrome (D+HUS). [read post]
12 Apr 2023, 7:35 am by Cyberleagle
Don’t expect to find every aspect of the Bill covered: you won’t find much on age-gating, despite (or perhaps because of) the dominant narrative that the Bill is about protecting children. [read post]
26 May 2021, 6:39 pm by Nate Nead
As we have been reminded throughout history, growth isn’t perpetual. [read post]
26 May 2021, 6:39 pm by Nate Nead
As we have been reminded throughout history, growth isn’t perpetual. [read post]
5 Nov 2007, 7:23 am
Center for Attention Deficit and Learning Disorders Phone: (602) 990-4474 Prescott area Marcia T. [read post]
29 Jun 2020, 2:41 am by Irene Marchioro (University of Bologna)
Bergamaschi, “L’esecuzione dei contratti ai tempi del coronavirus”, in “Il Quotidiano Giuridico”, 2020. [read post]
25 Jul 2022, 6:30 pm
This represents a most interesting development of Western Hemispher and developing state Leninism, the transposibility of which remains uintested. [read post]
21 Apr 2015, 7:19 pm by Dennis Crouch
  If you don’t accept these terms, return the unopened package to your point of purchase. [read post]
12 Dec 2011, 4:55 am by Dianne Saxe
And the US government can’t seem to agree on anything. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]